首页> 外文期刊>Journal of skin cancer >Merkel Cell Carcinoma: The Past, the Present, and the Future
【24h】

Merkel Cell Carcinoma: The Past, the Present, and the Future

机译:默克尔细胞癌:过去,现在和未来

获取原文
获取原文并翻译 | 示例
           

摘要

Since the first description of the Merkel cell carcinoma by Cyril Toker in 1972, the number of studies has significantly increased over the last 4 decades. In this review, we will illustrate the historical background of the Merkel cell carcinoma beginning with the 19th century, the first description of the Merkel cell to the finding of the CK20 as a highly specific diagnostic marker and finally to the recently detected Merkel cell polyomavirus (MCPyV). Moreover, we will highlight the beginning of adjuvant therapeutic regimens with radiotherapy and chemotherapy and discuss the diagnostic work-up including imaging and histology of patients with Merkel cell carcinoma. Another very rapidly growing and interesting field of research is the development of patients' specific and tailored targeted therapy, in particular in patients with distant metastatic disease.
机译:自1972年西里尔·托克(Cyril Toker)首次描述默克尔细胞癌以来,在过去的40年中,研究数量已大大增加。在这篇综述中,我们将说明默克尔细胞癌的历史背景,始于19世纪,首先是对默克尔细胞的描述,首先是发现CK20作为高度特异性的诊断标志物,最后是最近发现的默克尔细胞多瘤病毒( MCPyV)。此外,我们将重点介绍放射疗法和化学疗法的辅助治疗方案的开始,并讨论包括默克尔细胞癌患者的影像学和组织学在内的诊断工作。另一个非常迅速发展且有趣的研究领域是开发患者的特异性和针对性的靶向疗法,尤其是在远处转移性疾病患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号